Geratherm Medical AG (GME.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold GME.DE in your mock portfolio yet.
Geratherm Medical AG appears modestly profitable with a very low PE ratio of 4.08 and EPS of €0.63, which suggests the market is pricing in limited growth or elevated risk. The valuation looks inexpensive on an earnings basis, but without clear evidence of revenue growth or margin expansion, the discount may reflect structural concerns. Overall, the numbers point to a cheap but unexciting earnings profile rather than a clear value opportunity.
The stock trades at €2.57, below its 200‑day moving average of €2.84, indicating a prevailing downward or lagging trend versus its longer-term price level. A 4.8% decline over the last month reinforces short-term weakness, while an RSI of 47.80 suggests neither oversold nor overbought conditions. Technically, this points to a weak trend without a clear momentum-based reversal signal yet.
Alternative data show limited growth signals: website traffic is modest at ~4,547 monthly visitors, with no evidence of strong digital traction. The company has 0 job openings and flat hiring momentum, suggesting no active expansion or scaling phase. Social media presence (549 YouTube subscribers, 805 LinkedIn followers) is small and largely stagnant, pointing to low brand reach and limited marketing or investor-relations push.
Overall, Geratherm Medical AG presents a mixed picture: the stock looks inexpensive on earnings, but technicals are weak and alternative data do not indicate strong growth or engagement. The low PE could represent either an undervalued opportunity or a value trap if earnings are not sustainable or growth remains muted. Given the current evidence, the outlook is best characterized as neutral, with more confirmation needed from future operating performance and demand indicators.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started